#ASCO24 live now Matteo Lambertini, MD PhD talking about the importance of counseling of young pts w/ lung cancer on the impact on sexuality and fertility of oncological tps 📍a very important topic not to be forgotten during onco consults ✅ survivorship IS part of cancer care OncoAlert

Go Luca Arecco, MD go !!!!! Super proud of our Università di Genova Ospedale San Martino Genova young team !!! OncoAlert #ASCO24

#ASCO24 I cannot be more proud and excited to see a colleague and most of all a Friend on THAT stage 🥹 so well deserve.. and this is just the beginning 💫💫 Luca Arecco, MD Matteo Lambertini, MD PhD Università di Genova

What a fantastic work by Luca Arecco, MD from Università di Genova Ospedale San Martino Genova in presenting at #ASCO24 the results of an interesting analysis on impact of hormone receptor status in the #BRCA BCY collaboration…so proud of you ❤️ OncoAlert #bcsm ASCO

Tra i 7 italiani vincitori del prestigioso ASCO Conquer Cancer Merit Award c'è anche Luca Arecco, MD, specializzando del Ospedale San Martino Genova e unige. La sua ricerca sul tumore al seno mira a identificare biomarcatori per predire la prognosi delle giovani pazienti con mutazione BRCA.

Congrats Luca Arecco, MD for your #ASCO24 presentation and publication in Annals of Oncology…so important findings for improving the care of #BreastCancer in young #BRCA carriers 🇮🇹💪🔝👏🤩 OncoAlert Università di Genova Eva Blondeaux Elisa Agostinetto ASCO The ASCO Post Conquer Cancer, the ASCO Foundation #bcsm

Finally, a huge thank to all co-authors and researchers from 78 centers worldwide for participating in this international academic effort! 🌍🤝 Università di Genova Ospedale San Martino Genova Institut Jules Bordet Instituut Evandro de Azambuja, MD, PhD OncoAlert ESMO - Eur. Oncology Annals of Oncology #bcsm

Excited to contribute to the International Breast Pathology Course in the beautiful Mexico City w many experts in breast cancer field! Thank you for the kind invitation COMEGO, A.C. Miguel Angel Lopez Valle Roberto Sánchez-Reyes Carlos Gonzalez Santiesteban Elisa Agostinetto Evandro de Azambuja, MD, PhD Matteo Lambertini, MD PhD

I would sincerely thank my Università di Genova Ospedale San Martino Genova proff. Lucia Del Mastro and Matteo Lambertini, MD PhD for the opportunity to follow this study during my residency and for allowing me to conduct this first analysis Thanks to #SimonaPa, Maria Maddalena Latocca and Eva Blondeaux for all the support

Thrilled to share our latest article just published in Annals of Oncology regarding the role of liquid biopsy CGP in patients with RAS/BRAF wt MSS metastatic colorectal cancer enrolled in the CAPRI-2 GOIM study IEO ESMO - Eur. Oncology annalsofoncology.org/article/S0923-…

👏ESMO is pleased to announce the 2024 ESMO Research #Fellowship awardees who will be recognised during the #YoungOncologists Fellowship session at #ESMO24. The awardees are Luca Arecco, MD, @fedgiugliano, Ashray Gunjur, Daniël Lionarons, and Caterina Vaghi 📌ow.ly/W8Rq50TeAeF

I couldn't be more grateful and proud for this opportunity! Thank you to my stellar mentors Matteo Lambertini, MD PhD and Evandro de Azambuja, MD, PhD for believing in this project and to ESMO - Eur. Oncology for selecting me for this research fellowship 🙏🏼 Can't wait to be in #ESMO24 in #Barcelona to celebrate🥂🇪🇸

🧬 Honored to present data on CTCs and ctDNA analysis on eBC pts! - Low CTCs correlate with pCR regardless BC subtype 📈 - cfDI index may be useful in predicting pCR in BC pts but we need to select pts according to BC subtypes 💥 OncoAlert Università di Genova ESMO - Eur. Oncology

I couldn’t be more proud of being awarded as one of the ESMO - Eur. Oncology Clinical Research Fellow 2024, which will allow me to continue my research among Ospedale San Martino Genova and Institut Jules Bordet Instituut! Deeply grateful to Matteo Lambertini, MD PhD and Evandro de Azambuja, MD, PhD for supporting me and this research proposal! 🙏🏼

Just released the 2nd version of the ESMO - Eur. Oncology Essentials for Clinicians - Breast Cancer. Honoured to have contributed w a chapter purely focused on BC in #young women. Thanks to Matteo Lambertini, MD PhD for this opportunity and to ESMO - Eur. Oncology editorial team for this effort! OncoAlert

Thank you Matteo Lambertini, MD PhD for all the work you have done as chair of ESMO - Eur. Oncology #YOC for the new generations of oncologists all over the 🌍! There is no better way to inspire young oncologists than to have great mentors like you. Ad maiora!

Really excited and grateful to see a full session at #SABCS24 focusing on the management of #BreastCancer in young women…starting at 4 pm today December 10 in Stars at Night 1 2 OncoAlert SABCS Università di Genova Ospedale San Martino Genova VIRGINIA KAKLAMANI Carlos L. Arteaga, M.D. #bcsm Young Survival Coalition

I couldn't be more proud of my Università di Genova colleague and friend Andrea Boutros for such a prestigious fellowship at Melanoma Institute Australia! Great projects ongoing, including to assess the impact of immunotherapy and target tps on male fertility👏🏼 Matteo Lambertini, MD PhD Lucia Del Mastro OncoAlert

Published in JNCI our analysis assessing the prognosis of patients considered at high risk of recurrence according to #monarchE and #NATALEE trials inclusion criteria! 📄: academic.oup.com/jnci/advance-a… Eva Blondeaux Matteo Lambertini, MD PhD Lucia Del Mastro OncoAlert Main findings here👇🏼

Join OncoAlert 🚨& VJ Oncology Journal Club Prognostic implications of risk definitions from monarchE & NATALEE with a special walkthrough from lead author Luca Arecco, MD 🇮🇹 Listen on Apple Podcasts: podcasts.apple.com/se/podcast/onc… Study compared the prognostic impact of differing